|Articles|December 1, 2006 (Updated: November 15, 2020)
- Pharmaceutical Executive-12-01-2006
- Volume 0
- Issue 0
Eygptian Pharmaceuticals: Horizon 2010
Advertisement
Articles in this issue
about 19 years ago
Thoughtleader: Thomas Ebeling, Novartisabout 19 years ago
Forecasting Medicare: Price Controls in the Years Aheadabout 19 years ago
FDA vs. the Individualabout 19 years ago
Legal: E-headacheabout 19 years ago
From the Editor: Taken Awayabout 19 years ago
Global Report: Not So NICEabout 19 years ago
Confessions of a Serial Whistleblowerabout 19 years ago
Marketing to Professionals: Fax Me!about 19 years ago
PipelineNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Country Report: Canada
Published: | Updated:
Country Report: Poland
Published: | Updated:
Country Report: India
Published: | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5